- Home
- PED vs ARMP Comparison
PED vs ARMP Comparison
Compare PED & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- ARMP
- Stock Information
- Founded
- PED N/A
- ARMP N/A
- Country
- PED United States
- ARMP United States
- Employees
- PED N/A
- ARMP N/A
- Industry
- PED Oil & Gas Production
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PED Energy
- ARMP Health Care
- Exchange
- PED Nasdaq
- ARMP Nasdaq
- Market Cap
- PED 48.8M
- ARMP 52.1M
- IPO Year
- PED N/A
- ARMP N/A
- Fundamental
- Price
- PED $0.64
- ARMP $1.95
- Analyst Decision
- PED Strong Buy
- ARMP Strong Buy
- Analyst Count
- PED 2
- ARMP 1
- Target Price
- PED $1.63
- ARMP $9.00
- AVG Volume (30 Days)
- PED 102.3K
- ARMP 624.1K
- Earning Date
- PED 05-15-2025
- ARMP 05-14-2025
- Dividend Yield
- PED N/A
- ARMP N/A
- EPS Growth
- PED 2248.88
- ARMP N/A
- EPS
- PED 0.19
- ARMP N/A
- Revenue
- PED $40,173,000.00
- ARMP $4,699,000.00
- Revenue This Year
- PED N/A
- ARMP $8.43
- Revenue Next Year
- PED $5.99
- ARMP N/A
- P/E Ratio
- PED $3.36
- ARMP N/A
- Revenue Growth
- PED 30.70
- ARMP 14.24
- 52 Week Low
- PED $0.47
- ARMP $0.90
- 52 Week High
- PED $1.10
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- PED 56.52
- ARMP 56.79
- Support Level
- PED $0.59
- ARMP $1.74
- Resistance Level
- PED $0.66
- ARMP $2.20
- Average True Range (ATR)
- PED 0.04
- ARMP 0.32
- MACD
- PED 0.00
- ARMP 0.04
- Stochastic Oscillator
- PED 69.62
- ARMP 50.32
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.